Ryffel B et al. |
Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. |
1995 |
Immunopharmacology |
pmid:8557519
|
Stillman IE et al. |
FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. |
1995 |
Lab. Invest. |
pmid:8558840
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
Shirakata Y et al. |
Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. |
1995 |
Transplantation |
pmid:8545894
|
Klintmalm GB and Gonwa TA |
Nephrotoxicity associated with cyclosporine and FK506. |
1995 |
Liver Transpl Surg |
pmid:9346596
|
Wong PY et al. |
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. |
1995 |
Liver Transpl Surg |
pmid:9346613
|
Coghlan VM et al. |
Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. |
1995 |
Science |
pmid:7528941
|
Marx SO et al. |
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. |
1995 |
Circ. Res. |
pmid:7532117
|
Lang T et al. |
Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. |
1995 |
Transplant. Proc. |
pmid:7533367
|
Takeda Y et al. |
Effect of FK 506 on the expression of endothelin receptor mRNA in the vasculature. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587392
|
O'Rourke M et al. |
Recovery of delayed-type hypersensitivity following liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533369
|
Goodall T et al. |
FK506-induced endothelin release by cultured rat mesangial cells. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587453
|
Gaweco AS et al. |
Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression. |
1995 |
Transplant. Proc. |
pmid:7533370
|
Soldin SJ |
Receptor (immunophilin-binding) assay for immunosuppressive drugs. |
1995 |
Ther Drug Monit |
pmid:8588223
|
Armstrong VW et al. |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533371
|
Thomson AW et al. |
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. |
1995 |
Ther Drug Monit |
pmid:8588225
|
Martinez OM et al. |
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533372
|
Fung JJ and Starzl TE |
FK506 in solid organ transplantation. |
1995 |
Ther Drug Monit |
pmid:8588226
|
Langrehr JM et al. |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. |
1995 |
Transplant. Proc. |
pmid:7533373
|
Jusko WJ |
Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring. |
1995 |
Ther Drug Monit |
pmid:8588227
|
Chakraborty TK et al. |
Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. |
1995 |
Chem. Biol. |
pmid:9383417
|
Izutani H et al. |
Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. |
1995 |
Transplant. Proc. |
pmid:7533425
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Laskow DA et al. |
Phase II FK 506 multicenter concentration control study: one-year follow-up. |
1995 |
Transplant. Proc. |
pmid:7533431
|
Shapiro R et al. |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533432
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Jiang H et al. |
Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. |
1995 |
J. Invest. Dermatol. |
pmid:7535825
|
Atkison P et al. |
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. |
1995 |
Lancet |
pmid:7535875
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Bronster DJ et al. |
Demyelinating sensorimotor polyneuropathy after administration of FK506. |
1995 |
Transplantation |
pmid:7535959
|
Sheppard KE |
Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function. |
1995 |
J. Neuroendocrinol. |
pmid:8748119
|
Iwasaki K et al. |
Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. |
1995 |
Drug Metab. Dispos. |
pmid:7536652
|
Winkler M and Christians U |
A risk-benefit assessment of tacrolimus in transplantation. |
1995 |
Drug Saf |
pmid:7545405
|
Miranker A and Karplus M |
An automated method for dynamic ligand design. |
1995 |
Proteins |
pmid:8749844
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Victor RG et al. |
Presynaptic modulation of cortical synaptic activity by calcineurin. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7541535
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
McDiarmid SV et al. |
The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. |
1995 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:7541834
|
Adachi M et al. |
IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor beta chain. |
1995 |
FEBS Lett. |
pmid:7556630
|
David M et al. |
[Occurrence of suspicious changes in cervix cytology in women after liver transplantation]. |
1995 |
Geburtshilfe Frauenheilkd |
pmid:7557217
|
|
[Experimental and clinical studies on the effectiveness of new immunosuppressive agents used in heart transplantation and transplantation-related complications]. |
1995 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7561285
|
Lee TK et al. |
Postoperative selective bowel decontamination prevents gram-negative bacterial translocation in small-bowel graft recipients. |
1995 |
J. Surg. Res. |
pmid:7538186
|
Asano K et al. |
Generation of effector T cells in Hymenolepis nana-infected, FK-506-treated BALB/c mice. |
1995 |
Immunol. Lett. |
pmid:7590919
|
Lam E et al. |
A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. |
1995 |
J. Biol. Chem. |
pmid:7592869
|
Galat A and Metcalfe SM |
Peptidylproline cis/trans isomerases. |
1995 |
Prog. Biophys. Mol. Biol. |
pmid:7538221
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
Jurim O et al. |
Living-donor liver transplantation at UCLA. |
1995 |
Am. J. Surg. |
pmid:7538267
|
Conde M et al. |
Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. |
1995 |
Immunology |
pmid:7538492
|
Skeen MJ and Ziegler HK |
Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. |
1995 |
J. Immunol. |
pmid:7538532
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Rouvière-Fourmy N et al. |
1H and 15N assignment of NMR spectrum, secondary structure and global folding of the immunophilin-like domain of the 59-kDa FK506-binding protein. |
1995 |
Eur. J. Biochem. |
pmid:7544285
|
Sakamoto K et al. |
A new assay method for immunosuppressants with a tacrolimus (FK506)-like mode of action. |
1995 |
J. Antibiot. |
pmid:7544337
|
Lee MJ et al. |
Combined inhibition effects of tacrolimus and methylprednisolone on in vitro human lymphocyte proliferation. |
1995 |
Immunopharmacol Immunotoxicol |
pmid:7544367
|
Sauer P et al. |
In patients with orthotopic liver transplantation, serum markers of cholestasis are unreliable indicators of biliary secretion. |
1995 |
J. Hepatol. |
pmid:7544368
|
Nielsen FT et al. |
Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity. |
1995 |
Nephrol. Dial. Transplant. |
pmid:7540737
|
Chang HY et al. |
Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. |
1995 |
Nature |
pmid:7544441
|
Reichenspurner H et al. |
First experience with FK 506 for treatment of chronic pulmonary rejection. |
1995 |
Transplant. Proc. |
pmid:7540775
|
Yumiba T et al. |
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7540780
|
Horne SM and Young KD |
Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. |
1995 |
Arch. Microbiol. |
pmid:7540828
|
Teutsch M et al. |
Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. |
1995 |
Int. Immunol. |
pmid:7540861
|
Platz KP et al. |
Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation. |
1995 |
Clin Transplant |
pmid:7549052
|
Mueller AR et al. |
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506? |
1995 |
Clin Transplant |
pmid:7549057
|
Nagai H et al. |
Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. |
1995 |
Int. Arch. Allergy Immunol. |
pmid:7549508
|
Ma J et al. |
Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein. |
1995 |
Biophys. J. |
pmid:8599646
|
Lake KD and Canafax DM |
Important interactions of drugs with immunosuppressive agents used in transplant recipients. |
1995 |
J. Antimicrob. Chemother. |
pmid:8601538
|
DÃaz M et al. |
[Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)]. |
1995 Apr-Jun |
Rev Med Univ Navarra |
pmid:7569553
|
Hisatomi K et al. |
Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats. |
1995 Jan-Feb |
J. Heart Lung Transplant. |
pmid:7537098
|
DÃaz M et al. |
[Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)]. |
1995 Jan-Mar |
Rev Med Univ Navarra |
pmid:14735715
|
Kawahara K et al. |
Effects of deoxyspergualin on bronchial anastomosis healing in canine pulmonary allografts. |
1995 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7578196
|
Motoyama K et al. |
Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats. |
1995 Mar-Apr |
World J Surg |
pmid:7538717
|
Okudaira H et al. |
Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by down-regulation of interleukin-5 gene transcription. |
1995 May-Jun |
Int. Arch. Allergy Immunol. |
pmid:7542077
|
Su Q et al. |
Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase. |
1995 May-Jun |
Ren. Physiol. Biochem. |
pmid:7542793
|
Hayashi S et al. |
Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation. |
1995 May-Jun |
J. Heart Lung Transplant. |
pmid:7544621
|
Castillo Lugo JA |
Clinical and experimental immunosuppression. |
1995 May-Jun |
Bol Asoc Med P R |
pmid:8573248
|
Seifeldin R |
Drug interactions in transplantation. |
1995 Nov-Dec |
Clin Ther |
pmid:8750397
|
Schreiber SL and Crabtree GR |
Immunophilins, ligands, and the control of signal transduction. |
1995-1996 |
Harvey Lect. |
pmid:9127988
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Hashikura Y et al. |
Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623218
|
Craescu CT et al. |
Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution. |
1996 |
Biochemistry |
pmid:8780506
|
Singh N and Yu VL |
Prophylaxis for cytomegalovirus disease after liver transplant. |
1996 |
Clin. Infect. Dis. |
pmid:8783744
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Velio P et al. |
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506. |
1996 |
Transplant. Proc. |
pmid:8907936
|
Ichinari H et al. |
Effects of portal venous inoculation with donor splenocytes on lung allograft survival in dogs. |
1996 |
J. Thorac. Cardiovasc. Surg. |
pmid:8751494
|
Sunyecz JA et al. |
Lymphoproliferative disorder involving the cervix in a patient being treated with FK-506. |
1996 |
Gynecol. Oncol. |
pmid:8751565
|
Rambusch EG and Manns MP |
[Therapy of autoimmune hepatitis]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8998922
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Yoshida Y et al. |
Effect of lipoprostaglandin E1 in concordant xenografts. |
1996 |
Transplant. Proc. |
pmid:8658716
|
Kawauchi M et al. |
Which are the target vessels of xeno- and allo-lung rejection?--a primate single lung transplantation study. |
1996 |
Transplant. Proc. |
pmid:8658719
|
Sakimoto H et al. |
Administration of tacrolimus (FK506) in hamster-to-rat pancreas xenotransplantation. |
1996 |
Transplant. Proc. |
pmid:8658727
|
Chen BG et al. |
Inhibition by CsA and FK506 of the in vitro proliferative response of gamma delta T cells on stimulation with anti-TCR delta monoclonal antibody. |
1996 |
Transpl. Immunol. |
pmid:8843593
|
Toyota N et al. |
Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. |
1996 |
Arch. Dermatol. Res. |
pmid:8844128
|
Halloran PF |
Molecular mechanisms of new immunosuppressants. |
1996 |
Clin Transplant |
pmid:8680047
|
Luan S et al. |
Molecular characterization of a FKBP-type immunophilin from higher plants. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8692927
|
Dawson S et al. |
UCLA liver transplantation: analysis of immunological factors affecting outcome. |
1996 |
Artif Organs |
pmid:8896726
|
Kashu Y et al. |
Prolongation of rat liver graft survival by splenectomy combined with low dose FK506 therapy. |
1996 |
Artif Organs |
pmid:8896731
|
Yagita Y et al. |
Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. |
1996 |
Life Sci. |
pmid:8913329
|
Wang X et al. |
Rapamycin inhibits aldolase A expression during human lymphocyte activation. |
1996 |
J. Cell. Biochem. |
pmid:8913875
|
Vilquin JT et al. |
Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. |
1996 |
J. Cell Biol. |
pmid:8601607
|
Schuetz EG et al. |
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. |
1996 |
Mol. Pharmacol. |
pmid:8632764
|